Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.

    Uncategorized Posts

    New Type of Immunotherapy

    November 26th, 2020
    New type of immunotherapy may pave the way for better cancer treatments by Karolinska Institutet From left: First author Silke Eisinger and last author Mikael Karlsson from Karolinska Institutet in Sweden. Credit: Mitch Eisinger Immunotherapy for…

    Read Article

    SARCOMA: SEARCHING FOR CAUSES AND CURES

    November 18th, 2020
    Karina Galoian, Ph.D., is a research associate professor in the Department of Orthopaedics at the University of Miami Leonard M. Miller School of Medicine. She also leads the departmental Institutional Review Board and is Research Director of the…

    Read Article

    Virtual Dialogue Zoom Meeting URL

    November 17th, 2020
    Last Reminder. We go live at 7:15PM EST (New York time) tonight. We noticed that several of you have tested the connection and are ready to go. If you have any difficulties, Text me at 301-404-7100 We have 109 registrations. Looking forward to…

    Read Article

    Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    November 13th, 2020
    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

    Read Article

    Virtual Dialogue has 93 Registrations Far Exceeding Expectations


    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

    Read Article

    Seventy Registrations for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 30th, 2020

    Read Article

    Results of A Phase 1 Study on Ivosidenib for Patients with Advanced Chondrosarcoma

    October 23rd, 2020
    Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD,…

    Read Article

    Clinical Trial on IDH1 Inhibitor Shows Success in Decreasing Chondrosarcoma Cells

    October 21st, 2020
    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina…

    Read Article

    Invitation to Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 20th, 2020
    Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma…

    Read Article

    Clinical Research Study by Jonathan Trent on Effectiveness of IDH Inhibitors in Chondrosarcoma

    October 19th, 2020
    The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD Jonathan Trent, M.D., Ph.D. is a world…

    Read Article

    Contact Information


    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message